Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura W Dillon

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
JCI Insight|December 7, 2018
Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometryKarolyn A Oetjen, Katherine E Lindblad, Meghali Goswami, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid LeukemiaNiveditha Ravindra, Justin Lack, Clifton L Dalgard, et al.
Haematologica|September 30, 2021
Utility of plasma cell-free DNA for <i>de novo</i> detection and quantification of clonal hematopoiesisFernanda Gutierrez-Rodrigues, Isabel Beerman, Emma M Groarke, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemiaLaura W Dillon, Jake Higgins, Hassan Nasif, et al.
Haematologica|August 3, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemiaLaura W Dillon, Jake Higgins, Hassan Nasif, et al.
Haematologica|May 28, 2026
Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in acute myeloid leukemia in first complete remission: CIBMTR analysisJesse M Tettero, Mei-Jie Zhang, Wentong Liu, et al.
Blood Neoplasia|August 14, 2025
Checkpoint immunotherapy is associated with preferential activation of tumor antigen-specific CD4<sup>+</sup> T cells in MDSElizabeth A Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Single Cell Spatial Transcriptomics Reveals Immunotherapy-Driven Bone Marrow Niche Remodeling in AMLGege Gui, Molly A Bingham, Julius R Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 StudyJurjen Versluis, Wael Saber, Harrison K Tsai, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Pathogenic TERT promoter variants in telomere diseasesFernanda Gutierrez-Rodrigues, Flávia S Donaires, André Pinto, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
JCI Insight|December 7, 2018
Human bone marrow assessment by single-cell RNA sequencing, mass cytometry, and flow cytometryKarolyn A Oetjen, Katherine E Lindblad, Meghali Goswami, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Whole Genome Sequencing Informed Patient Personalized Measurable Residual Disease Assays for Acute Myeloid LeukemiaNiveditha Ravindra, Justin Lack, Clifton L Dalgard, et al.
Haematologica|September 30, 2021
Utility of plasma cell-free DNA for <i>de novo</i> detection and quantification of clonal hematopoiesisFernanda Gutierrez-Rodrigues, Isabel Beerman, Emma M Groarke, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemiaLaura W Dillon, Jake Higgins, Hassan Nasif, et al.
Haematologica|August 3, 2023
Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemiaLaura W Dillon, Jake Higgins, Hassan Nasif, et al.
Haematologica|May 28, 2026
Real-world heterogeneity in the prognostic value of pre-transplant flow cytometry measurable residual disease in acute myeloid leukemia in first complete remission: CIBMTR analysisJesse M Tettero, Mei-Jie Zhang, Wentong Liu, et al.
Blood Neoplasia|August 14, 2025
Checkpoint immunotherapy is associated with preferential activation of tumor antigen-specific CD4<sup>+</sup> T cells in MDSElizabeth A Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, et al.
Biorxiv : the Preprint Server for Biology|February 20, 2025
Single Cell Spatial Transcriptomics Reveals Immunotherapy-Driven Bone Marrow Niche Remodeling in AMLGege Gui, Molly A Bingham, Julius R Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2023
Allogeneic Hematopoietic Cell Transplantation Improves Outcome in Myelodysplastic Syndrome Across High-Risk Genetic Subgroups: Genetic Analysis of the Blood and Marrow Transplant Clinical Trials Network 1102 StudyJurjen Versluis, Wael Saber, Harrison K Tsai, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 8, 2018
Pathogenic TERT promoter variants in telomere diseasesFernanda Gutierrez-Rodrigues, Flávia S Donaires, André Pinto, et al.
Pageof 5